---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-22-000032"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:24:53.437521+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# EVP & General Counsel Michelle Basil to depart Haemonetics by Oct 31, 2022

## Summary
- Michelle L. Basil, EVP and General Counsel, will transition from Haemonetics effective October 31, 2022.
- She will remain in her role through the Retention Date to ensure a seamless transition while a successor is sought.
- Under the Agreement, she will receive a $500,000 retention bonus if she stays through Oct 31 without resignation or cause termination.
- Her base salary continues unchanged and outstanding equity awards vest through Retention Date; she will not receive FY2023 short-term incentive bonus.

## SEC filing metadata
- accession: 0000313143-22-000032
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314322000032/0000313143-22-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314322000032/hae-20220611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-22-000032
- JSON: https://secwatch.observer/filing/0000313143-22-000032.json
- Plain text: https://secwatch.observer/filing/0000313143-22-000032.txt

## Key facts
- Executive change
  Michelle L. Basil changed role as Executive Vice President, General Counsel at HAEMONETICS CORP.
  - Action: transition
  - Role: Executive Vice President, General Counsel
  source text: On June 16, 2022, Haemonetics Corporation (the “Company”) announced that Michelle L. Basil, Executive Vice President, General Counsel has decided to transition from the Company effective October 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314322000032/0000313143-22-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.